Clinical trial
Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease
NCT05349318
Study timeline
Study start (actual)2022-03-31Date precision: day
Registry last updated2024-02-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prodromal Alzheimer's Diseaseunresolved
Cerebral Vascular Disorderunresolved
Mild Cognitive Impairmentunresolved
Vascular Cognitive Impairmentunresolved
Interventions
ShamDEVICE
Sponsors & collaborators
Assaf-Harofeh Medical Centerlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05349318 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.